Who are Cannabis Bioscience International Holdings, Inc.'s main suppliers?

Cannabis Bioscience International Holdings, Inc. (CBIH) key suppliers include: GEORGE-OPARA, UNRELATED-PARTY-JANUARY-2023, UNRELATED-PARTY-MAY-2022, SBA-EIDL. View the full supplier network at chainsifter.com/chain/CBIH.

Who are Cannabis Bioscience International Holdings, Inc.'s major customers?

Cannabis Bioscience International Holdings, Inc. (CBIH) key customers include: ALPHA-RESEARCH-BUSINESS, COVANCE, GLAXOSMITHKLINE-PLC, ICON-PLC, IQVIA-HOLDINGS-INC and 14 more. View the full customer network at chainsifter.com/chain/CBIH.

What sector is Cannabis Bioscience International Holdings, Inc. in?

Cannabis Bioscience International Holdings, Inc. (CBIH) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

CBIH Supply Chain: Cannabis Bioscience International Holdings, Inc. Supplier List & 24 Relationships

4Suppliers

19Customers

1Debt Items

20Related Chains

Cannabis Bioscience International Holdings, Inc. Suppliers

Ticker	Name	Confidence	Evidence
GEORGE-OPARA	GEORGE-OPARA	92%	On March 20, 2026, the Company entered into an agreement resulting in the issuance of 20,000,000 shares of its common stock to George Opara. The shares were issued as compensation for professional se…
UNRELATED-PARTY-JANUARY-2023	UNRELATED-PARTY-JANUARY-2023	90%	In January 2023, the Company entered into a financing agreement with an unrelated party for a loan of $ 20,000 , bearing interest at the rate of 33.5 % per annum, to be repaid at the rate of $1,874 p…
UNRELATED-PARTY-MAY-2022	UNRELATED-PARTY-MAY-2022	90%	In May 2022, the Company entered into a financing agreement with an unrelated party for a loan of $ 50,000 , bearing interest at the rate of 20.9 % per annum, to be repaid at the rate of $1,218 per w…
SBA-EIDL	SBA-EIDL	85%	The Company has entered into loans under which it borrowed money and financing agreements under which it sold receivables to third parties

Cannabis Bioscience International Holdings, Inc. Customers

Ticker	Name	Confidence	Evidence
ALPHA-RESEARCH-BUSINESS	ALPHA-RESEARCH-BUSINESS	90%	The Company has depended on a few customers of Alpha Research Business for substantial portions of its revenue.
COVANCE	COVANCE	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
GLAXOSMITHKLINE-PLC	GLAXOSMITHKLINE-PLC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
ICON-PLC	ICON-PLC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
IQVIA-HOLDINGS-INC	IQVIA-HOLDINGS-INC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
MDT	Medtronic plc	90%	Reciprocal relationship from MDT graph: Reciprocal relationship from CBIH graph: Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novart…
MEDPACE-HOLDINGS-INC	MEDPACE-HOLDINGS-INC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
MEDTRONIC-PLC	MEDTRONIC-PLC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
MERCK-CO-INC	MERCK-CO-INC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
NVS	Novartis AG	90%	Reciprocal relationship from NVS graph: Reciprocal relationship from CBIH graph: Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novart…
NVS	Novartis AG	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
PAREXEL	PAREXEL	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
PFIZER-INC	PFIZER-INC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
PHARMACOLOGY-UNIVERSITY	PHARMACOLOGY-UNIVERSITY	90%	On December 31, 2025, the Company terminated its Pharmacology University business.
PPD-INC	PPD-INC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
PRA-HEALTH-SCIENCES-INC	PRA-HEALTH-SCIENCES-INC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
THREE-CUSTOMERS	THREE-CUSTOMERS	90%	The Company had three customers that provided 99 % of gross revenue for the quarter ended November 30, 2025
TWO-CUSTOMERS	TWO-CUSTOMERS	90%	two customers that provided 98 % of gross revenue for the quarter ended November 30, 2024
VITA-BIOTECH-RESEARCH-LLC	VITA-BIOTECH-RESEARCH-LLC	90%	One of our clients is Vita Biotech Research, LLC ("Vita"), which is engaged in data collection for clinical trials.

Cannabis Bioscience International Holdings, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
CBIH-DEBT	Debt stack $1.2M	90%	Market cache reports total debt of $1.2M.

Cannabis Bioscience International Holdings, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Cannabis Bioscience International Holdings, Inc..

Cannabis Bioscience International Holdings, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Cannabis Bioscience International Holdings, Inc..

Cannabis Bioscience International Holdings, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
SNNUF	Smith & Nephew plc	100.00	2
SUPN	Supernus Pharmaceuticals, Inc.	100.00	2
DYN	Dyne Therapeutics, Inc.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
ALC	Alcon Inc.	100.00	2
ANIK	Anika Therapeutics, Inc.	100.00	2
EDSA	Edesa Biotech, Inc.	100.00	2
CHRS	Coherus Oncology, Inc.	100.00	2
AORT	Artivion, Inc.	100.00	2
AVBP	ArriVent BioPharma, Inc.	100.00	2
BNBX	BNB Plus Corp.	100.00	2
CTMX	CytomX Therapeutics, Inc.	100.00	2
AVIR	Atea Pharmaceuticals, Inc.	100.00	2
IMMP	Immutep Limited	100.00	2
BLLN	BillionToOne, Inc.	100.00	2
BNR	Burning Rock Biotech Limited	100.00	2
BNRG	Brenmiller Energy Ltd	100.00	2
CSTE	Caesarstone Ltd.	100.00	2
PSNL	Personalis, Inc.	100.00	2
ATRA	Atara Biotherapeutics, Inc.	100.00	2

Cannabis Bioscience International Holdings, Inc. Supply Chain